HSBC Holdings
MIRM icon

HSBC Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

HSBC Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,330
Closed -$272K – 2983
2025
Q2 		$272K Sell
5,330
-363
-6% -$16.2K ﹤0.01% 2516
2025
Q1 		$257K Sell
5,693
-811
-12% -$38.2K ﹤0.01% 2472
2024
Q4 		$269K Buy
+6,504
New +$271K ﹤0.01% 2559
2019
Q4 		– Sell
-20,792
Closed -$209K – 3139
2019
Q3 		$209K Buy
+20,792
New +$255K ﹤0.01% 2845

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

HSBC Holdings's MIRM Position: Q3 2025 in Review

HSBC Holdings sold out of Mirum Pharmaceuticals (MIRM) in Q3 2025, closing a stake of 5,330 shares — an estimated $272K sold.

HSBC Holdings first reported a position in MIRM in Q3 2019 and held it in 4 quarters. The position peaked at $272K in Q2 2025. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

  • HSBC Holdings reported no remaining Mirum Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 5,330 Mirum Pharmaceuticals shares in Q3 2025, an estimated $272K.
  • HSBC Holdings first reported a position in Mirum Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • HSBC Holdings's Mirum Pharmaceuticals position peaked at $272K in Q2 2025.
  • 272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.